company background image
IDT logo

IDT Australia CHIA:IDT Stock Report

Last Price

AU$0.10

Market Cap

AU$43.0m

7D

0%

1Y

-4.8%

Updated

23 Dec, 2024

Data

Company Financials

IDT Australia Limited

CHIA:IDT Stock Report

Market Cap: AU$43.0m

IDT Stock Overview

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. More details

IDT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Earnings have declined by 22.1% per year over past 5 years

Does not have a meaningful market cap (A$43M)

Shareholders have been diluted in the past year


My Notes

Capture your thoughts, links and company narrative

IDT Australia Limited Competitors

Syntara

ASX:SNT

AU$82.4m

Medical Developments International

ASX:MVP

AU$45.6m

Little Green Pharma

ASX:LGP

AU$40.9m

Starpharma Holdings

ASX:SPL

AU$41.0m

Price History & Performance

Summary of share price highs, lows and changes for IDT Australia
Historical stock prices
Current Share PriceAU$0.10
52 Week HighAU$0.14
52 Week LowAU$0.077
Beta1.21
1 Month Change0%
3 Month Change-16.67%
1 Year Change-4.76%
3 Year Change-64.29%
5 Year Change-16.67%
Change since IPO-56.52%

Recent News & Updates

Recent updates

Shareholder Returns

IDTAU PharmaceuticalsAU Market
7D0%-4.9%-2.7%
1Y-4.8%-9.3%6.5%

Return vs Industry: IDT exceeded the Australian Pharmaceuticals industry which returned -9.3% over the past year.

Return vs Market: IDT underperformed the Australian Market which returned 6.5% over the past year.

Price Volatility

Is IDT's price volatile compared to industry and market?
IDT volatility
IDT Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement10.3%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: IDT has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: IDT's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1975n/aPaul McDonalden.idtaus.com.au

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services.

IDT Australia Limited Fundamentals Summary

How do IDT Australia's earnings and revenue compare to its market cap?
IDT fundamental statistics
Market capAU$42.98m
Earnings (TTM)-AU$5.41m
Revenue (TTM)AU$14.02m

3.1x

P/S Ratio

-7.9x

P/E Ratio

Is IDT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDT income statement (TTM)
RevenueAU$14.02m
Cost of RevenueAU$6.52m
Gross ProfitAU$7.50m
Other ExpensesAU$12.91m
Earnings-AU$5.41m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.013
Gross Margin53.46%
Net Profit Margin-38.61%
Debt/Equity Ratio19.1%

How did IDT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:31
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IDT Australia Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott PowerMorgans Financial Limited
Shane StoreyWilsons Advisory and Stockbroking Ltd.